NEW WHITE PAPER:  Solving Atypical Protein Expression with Transposase Technology    Dive in today!
Contact Us
Contact Us

AGC Biologics

2 min read

AGC Biologics to Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance

May 25, 2026 at 5:00 PM
Press Release Tech Transfer Microbial
Read press release
Logos of AGC Bio and Orphan Therapeutics shown to reflect new network partnership

2 min read

AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases

May 11, 2026 at 5:00 AM
Cell & Gene Therapy Press Release
Read press release
AGC Biologics and Novelty Nobility leaders meet to discuss GMP manufacturing of bispecific drug candidate, NN4101 in Tokyo, Japan on April 13, 2026.

2 min read

Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate

May 3, 2026 at 4:45 PM
Mammalian & mAbs Press Release Cell Line Development
Read press release
Image showing award logo

3 min read

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

April 27, 2026 at 8:30 AM
Read press release

2 min read

AGC Biologics Seattle site now certified to manufacture biologics for largest pharmaceutical market in South America

February 3, 2026 at 8:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
AGC Biologics and Fondazione Telethon celebrate regulatory approvals for gene therapy

3 min read

AGC Biologics Celebrates U.S. and EU Approval of Fondazione Telethon’s Waskyra™ Treatment for Wiskott-Aldrich Syndrome

January 16, 2026 at 11:00 AM
Cell & Gene Therapy Press Release
Read press release

2 min read

Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production

January 12, 2026 at 4:00 AM
Cell & Gene Therapy Press Release Business Updates
Read press release

3 min read

AGC Biologics Partners with ATUM to Accelerate Timelines for Cell Line Development

December 2, 2025 at 6:00 AM
Mammalian & mAbs Press Release Business Updates Cell Line Development
Read press release
AGC Biologics partners with AAVantgarde

3 min read

AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders

November 21, 2025 at 12:00 AM
Cell & Gene Therapy Press Release
Read press release
AGC Biologics today announced it is partnering with Repair Biotechnologies to tackle one of the world's most persistent health challenges and cause of mortality.

2 min read

AGC Biologics and Repair Biotechnologies Partner on Novel mRNA Therapeutic to Combat the Leading Cause of Human Mortality

November 19, 2025 at 12:00 AM
Press Release mRNA Content
Read press release
1 2 3 4 5 Next